BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLLN BillionToOne, Inc.

交易中 10-07 15:59:07 EDT

95.91

-4.03

-4.03%

最高99.60	最低94.52	成交量63.09万
今开99.37	昨收99.94	日振幅5.08%
总市值45.26亿	流通市值27.63亿	总股本4,719万
成交额6,099万	换手率2.19%	流通股本2,881万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":95.91,"timestamp":1791403145301,"preClose":99.94,"halted":0,"volume":630919,"delay":0,"changeRate":-0.04032419451671004,"floatShares":28813300,"shares":47187038,"eps":0.769017,"marketStatus":"交易中","change":-4.03,"latestTime":"10-07 15:59:07 EDT","open":99.37,"high":99.6,"low":94.52,"amount":60994700.007240005,"amplitude":0.05083,"askPrice":95.9,"askSize":70,"bidPrice":95.79,"bidSize":529,"shortable":3,"etf":0,"ttmEps":0.769017,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791403200000},"marketStatusCode":2,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":99.94,"preHourTrading":{"tag":"盘前","latestPrice":99.2,"preClose":99.94,"latestTime":"09:29 EDT","volume":1096,"amount":108991.627936,"timestamp":1791379799987,"change":-0.74,"changeRate":-0.007404,"amplitude":0.023514},"volumeRatio":0.901391,"impliedVol":0.6725,"impliedVolPercentile":0.2453},"requestUrl":"/m/hq/s/BLLN","defaultTab":"news","newsList":[{"id":"1173245394","title":"财报前瞻｜BillionToOne, Inc.本季度营收预计小幅增长，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1173245394","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173245394?lang=zh_cn&edition=full","pubTime":"2026-07-29 11:28","pubTimestamp":1785295724,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc.将于2026年08月05日发布财报，市场关注营收与盈利质量的结构性变化及单项业务的增长延续性。根据市场一致预期，本季度BillionToOne, Inc.预计营收为1.09亿美元，同比数据未披露；预计毛利率未披露；预计净利润或净利率未披露；预计调整后每股收益为0.18美元，同比数据未披露。主营来看，产前产品营收9,652.50万美元，占比89.06%；肿瘤学营收1,072.00万美元，占比9.89%；临床试验支持服务营收114.30万美元，占比1.05%，同比数据未披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜BillionToOne, Inc.本季度营收预计小幅增长，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190143234","title":"BillionToOne任命Ethan Dmitrovsky博士为肿瘤学首席医疗官，主导Northstar医疗战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1190143234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190143234?lang=zh_cn&edition=full","pubTime":"2026-07-20 21:02","pubTimestamp":1784552542,"startTime":"0","endTime":"0","summary":"BillionToOne已任命Ethan Dmitrovsky博士担任肿瘤学首席医疗官一职。他将负责领导公司Northstar项目的整体医疗战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184688689","title":"异动解读 | 古根海姆上调目标价至120美元，BillionToOne盘前大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184688689","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184688689?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:19","pubTimestamp":1778674751,"startTime":"0","endTime":"0","summary":"生物技术公司BillionToOne, Inc.（股票代码：BLLN）今日盘前股价大幅上涨6.12%，引起了市场的广泛关注。消息面上，古根海姆（Guggenheim）分析师将该公司的目标价从100美元上调至120美元，这一积极的评级调整提振了投资者信心，推动了股价在盘前交易时段的上涨。分析师上调目标价通常意味着对公司未来增长前景的看好，古根海姆此次上调BillionToOne的目标价，可能反映了对公司业务发展、财务状况或市场地位的积极评估，从而吸引了更多买盘入场。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133212466","title":"异动解读 | 获摩根大通上调目标价，BillionToOne盘中大涨13.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133212466","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133212466?lang=zh_cn&edition=full","pubTime":"2026-05-08 01:17","pubTimestamp":1778174274,"startTime":"0","endTime":"0","summary":"生物技术公司BillionToOne, Inc.今日盘中股价大幅上涨13.02%，引起了市场的广泛关注。消息面上，根据路透汇总的研究行动，摩根大通将BillionToOne的目标价从120美元上调至125美元。分析师上调目标价通常被视为对公司未来前景的积极看法，这可能是推动股价上涨的主要因素。与此同时，同一份研究报告也显示，另一家机构BTIG将BillionToOne的目标价从140美元下调至130美元。市场在今日盘中交易中，显然对摩根大通的上调行动给出了更积极的反应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113984069","title":"异动解读 | BTIG下调目标价，BillionToOne盘中大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113984069","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113984069?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:32","pubTimestamp":1778164345,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc.（BLLN）今日盘中股价大跌5.15%，引起了市场的广泛关注。消息面上，根据路透报道，华尔街分析师周四调整了对该公司的目标价。其中，BTIG将BillionToOne的目标价从140美元下调至130美元，而摩根大通则将目标价从120美元上调至125美元。市场对BTIG下调目标价的反应更为敏感，这可能是导致股价下跌的主要原因。分析师调整目标价通常反映了对公司未来业绩的预期变化，投资者据此调整持仓，从而引发股价波动。目前，市场正在消化这些新的评级信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186191201","title":"异动解读 | 获摩根大通上调目标价，BillionToOne盘前大涨8.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186191201","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186191201?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:07","pubTimestamp":1778152064,"startTime":"0","endTime":"0","summary":"生物技术公司BillionToOne, Inc.今日盘前股价大幅上涨8.29%，引起了市场关注。消息面上，根据路透汇总的研究行动，摩根大通将BillionToOne的目标价从120美元上调至125美元。分析师上调目标价通常被视为对公司未来前景的积极看法，这可能是推动股价上涨的主要因素。与此同时，同一份研究报告也显示，另一家机构BTIG将BillionToOne的目标价从140美元下调至130美元。市场在今日盘前交易中，显然对摩根大通的上调行动给出了更积极的反应。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147885199","title":"财报前瞻｜BillionToOne, Inc.本季营收预计9,688.50万美元，看多为主","url":"https://stock-news.laohu8.com/highlight/detail?id=1147885199","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147885199?lang=zh_cn&edition=full","pubTime":"2026-04-29 14:30","pubTimestamp":1777444228,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc.将于2026年05月06日发布2026年第一季度财报，市场聚焦收入延续性与利润率稳定性。当前一致预期本季度公司营收为美元9,688.50万，同比增速0.00%；调整后每股收益为0.05美元，同比增速0.00%；EBIT预计为美元301.67万，同比增速0.00%；上一季度披露中未给出本季度毛利率、净利率或归母净利润的具体预测。本季度市场预计营收为美元9,688.50万，在上一季度毛利率71.42%的基础上，若结构与成本假设大体延续，毛利规模有望受惠于量增带来的固定成本摊薄。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜BillionToOne, Inc.本季营收预计9,688.50万美元，看多为主","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.billiontoone.com","stockEarnings":[{"period":"1week","weight":-0.1543},{"period":"1month","weight":0.0055},{"period":"3month","weight":-0.1713},{"period":"6month","weight":0.2114},{"period":"1year","weight":0.6657},{"period":"ytd","weight":0.2212}],"compareEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0452},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BillionToOne, Inc.于2016年作为特拉华州公司开始运营。该公司开发了一种革命性的单分子下一代测序（smNGS）平台，能够以单分子灵敏度检测和精确量化基因靶标。这项创新的核心是其专利的定量计数模板（QCT），该模板可在单个DNA分子水平上进行测量。这项技术突破了医疗保健领域在检测游离DNA中稀疏但具有临床意义的疾病信号方面的一个关键瓶颈。BillionToOne的技术平台已成功应用于一系列开创性的产前和肿瘤学产品，这些产品仅需简单的血液样本即可提供可操作的诊断信息。","exchange":"NASDAQ","name":"BillionToOne, Inc.","nameEN":"BillionToOne, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BillionToOne, Inc.,BLLN,BillionToOne, Inc.股票,BillionToOne, Inc.股票老虎,BillionToOne, Inc.股票老虎国际,BillionToOne, Inc.行情,BillionToOne, Inc.股票行情,BillionToOne, Inc.股价,BillionToOne, Inc.股市,BillionToOne, Inc.股票价格,BillionToOne, Inc.股票交易,BillionToOne, Inc.股票购买,BillionToOne, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}